Pacritinib 100 MG Oral Capsule — RxCUI 2595248
RxNorm drug concept · Semantic clinical drug
RxCUI 2595248
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2595248
Official namePacritinib 100 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspacritinib 100 MG (as pacritinib citrate 141 MG) Oral Capsule
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)13 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Pacritinib: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Vonjo is used to treat a bone marrow disease called myelofibrosis — either the primary kind or a type that develops after another blood disorder. What makes it unique is that it's...
- What exactly is Vonjo used for, and why was it prescribed for me?
- You take Vonjo capsules twice a day — and the good news is you can take it with or without food, whichever is easier for you. Just swallow the capsules whole; don't open, crush, or...
- How do I take this medication, and does it matter if I take it with food?
🕸️ Concept Web — How Pacritinib 100 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Pacritinib 100 MG Oral Capsule
RxCUI 2595248 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Pacritinib
2595243IN
-
Pacritinib
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Vonjo
2595249BN
-
Vonjo
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Pacritinib Oral Capsule
2595247SCDF -
Pacritinib Oral Product
2595245SCDG -
Pacritinib Pill
2595246SCDG -
Pacritinib Oral Capsule [Vonjo]
2595253SBDF -
Vonjo Oral Product
2595251SBDG -
Vonjo Pill
2595252SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Pacritinib Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Pacritinib 100 MG
2595244SCDC -
Pacritinib 100 MG Oral Capsule [Vonjo]
2595254SBD -
Pacritinib 100 MG [Vonjo]
2595250SBDC
-
Pacritinib 100 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Pacritinib 100 MG
SCDC · 2595244 -
Pacritinib Oral Capsule
SCDF · 2595247 -
Pacritinib Oral Product
SCDG · 2595245 -
Pacritinib Pill
SCDG · 2595246
Brand-Name Concepts
-
Pacritinib 100 MG Oral Capsule [Vonjo]
SBD · 2595254 -
Pacritinib 100 MG [Vonjo]
SBDC · 2595250 -
Pacritinib Oral Capsule [Vonjo]
SBDF · 2595253 -
Vonjo Oral Product
SBDG · 2595251 -
Vonjo Pill
SBDG · 2595252 -
Vonjo
BN · 2595249
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2595248 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 72482-0100-12 | 40 CARTON in 1 BOX (72482-100-12) / 1 BOTTLE in 1 CARTON /... | Vonjo | Sobi, Inc. | 2022-02-28 |
Observed labelers:
Sobi, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.